Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/1996
09/03/1996US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy
09/03/1996US5552161 Low viscosity, highly concentrated surfactant suspension
09/03/1996US5552160 Surface modified NSAID nanoparticles
09/03/1996US5552159 Solid depot drug form
09/03/1996US5552157 Quaternary ammonium lipids
09/03/1996US5552156 Liposomal and micellular stabilization of camptothecin drugs
09/03/1996US5552155 Fusogenic lipsomes and methods for making and using same
09/03/1996US5552154 Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
09/03/1996US5552153 Pharmaceutical composition for transdermal delivery
09/03/1996US5552152 Controlled release tablet
09/03/1996US5552086 Gold and silver on polystyrene, useful for raman spectroscopy and flow cytometry, interlayer of aminodextran
09/03/1996US5551489 Agglomeration of finely divided powders
09/03/1996CA2033113C Estrogen-containing gel preparation
09/03/1996CA2025764C Gradual release structures made from fiber spinning techniques
09/03/1996CA2008972C Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
09/03/1996CA1338569C Controlled release therapeutic system for liquid pharmaceutical formulations
08/1996
08/29/1996WO1996026179A1 Novel cationic lipids and the use thereof
08/29/1996WO1996025952A1 Pharmaceuticals and assays using enzyme subunits
08/29/1996WO1996025951A1 Gel form of a vaccine
08/29/1996WO1996025950A1 Use of inorganic aerogels in pharmacy
08/29/1996WO1996025942A1 Cochleate phospholipids in drug delivery
08/29/1996WO1996025939A1 Use of piperine as a bioavailability enhancer
08/29/1996WO1996025935A1 Method of treating adenosine depletion
08/29/1996WO1996025925A1 Nasal and ocular administration of ketamine to manage pain and for detoxification
08/29/1996WO1996025923A1 A process for the preparation of an emulsion network for a transdermal drug delivery system
08/29/1996WO1996025922A2 Banded prolonged release active agent dosage form
08/29/1996WO1996025921A1 Polyalkylene block copolymers as surface modifiers for nanoparticles
08/29/1996WO1996025919A1 Aerosols containing beclomethazone nanoparticle dispersions
08/29/1996WO1996025918A1 Aerosols containing nanoparticle dispersions
08/29/1996WO1996025916A1 Method for preparing a preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders
08/29/1996WO1996025915A1 Improved hemostatic composition for treating gingival area
08/29/1996WO1996025910A1 Water-soluble pressure-sensitive mucoadhesive
08/29/1996WO1996025852A1 Composition for controlling parasites
08/29/1996WO1996025850A1 Use of aerogels in agriculture
08/29/1996WO1996018741A3 Liposome-mediated transfection of central nervous system cells
08/29/1996WO1996018406A3 Ophthalmic formulations of substituted glycosides
08/29/1996WO1996018388A3 Cross-linked microparticles and their use as therapeutic vehicles
08/29/1996DE19603402A1 Soft gelatin capsules
08/29/1996DE19519593C1 Transdermal therapeutic system with thermoplastic back layer
08/29/1996DE19506141A1 Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz Use of aerogels in the pharmaceutical, cosmetics and phytosanitary
08/29/1996CA2213569A1 Use of aerogels in agriculture
08/29/1996CA2213566A1 Pharmaceuticals and assays using enzyme subunits
08/29/1996CA2213511A1 Use of inorganic aerogels in pharmacy
08/29/1996CA2213417A1 Novel cationic lipids and the use thereof
08/29/1996CA2213408A1 Improved hemostatic composition for treating soft tissue
08/28/1996EP0728485A2 Composition for external treatment of the hoof mycosis of the unguiculates, particularly the horse
08/28/1996EP0728480A1 Use of ifenprodil for treatment of elevated intraocular pressure
08/28/1996EP0728479A1 Deacetyl moxisylyte in the treatment of acute urinary retention
08/28/1996EP0728477A2 Compositions for topical administration of pharmaceutically active agents
08/28/1996EP0728476A1 Liposome composition
08/28/1996EP0728475A2 Skin cleanser
08/28/1996EP0728460A1 Transparent nanoemulsion based on amphiphilic nonionic lipids and use in cosmetics or dermapharmacy
08/28/1996EP0728200A1 Haemophilus transferrin receptor genes
08/28/1996EP0728195A1 Methods for preserving recombinant viruses
08/28/1996EP0728013A1 Compositions and method for stimulating antibody release by b lymphocytes
08/28/1996EP0728008A1 Application of trace elements to animals
08/28/1996EP0728006A1 Use of mannose phosphates for the treatment of fibrotic disorders
08/28/1996EP0727999A1 Treatment of immunoregulatory disorders
08/28/1996EP0727997A1 Pharmaceutical emulsion
08/28/1996EP0727996A1 Fenbendazole formulations
08/28/1996EP0727991A1 Compositions containing zinc linoleate for the treatment of skin disorders
08/28/1996EP0727988A1 Aids prophylactic lubricating composition and devices for its use
08/28/1996EP0727985A1 Composition and method for treating blood vessel disorders of the skin using vitamin k
08/28/1996EP0727984A1 Controlled release preparation
08/28/1996EP0727983A1 Process for preparing a clodronate preparation
08/28/1996EP0727982A1 Propylene glycol stearate vesicles
08/28/1996EP0727979A1 Novel composition
08/28/1996EP0727978A1 Topical aromatic releasing compositions
08/28/1996EP0727959A1 Diagnostic uses of hydrazinoadenosines
08/28/1996EP0678026B1 Application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes
08/28/1996EP0571541B1 Lipid vesicles having an alkyd as a wall-forming material
08/28/1996EP0536226B1 The combination of growth hormone and insulin-like growth factor-i enhances growth
08/28/1996EP0476045B1 Bioerodible polymers for drug delivery in bone
08/28/1996CN1129947A Polymeric matrices and their uses in pharmaceutical compositions
08/28/1996CN1129932A Salmeterol kinafoate with controlled particular size
08/28/1996CN1129905A Iontophoretic delivery of an antimigraine drug
08/28/1996CN1129904A Therapeutic preparation for inhalation
08/28/1996CN1129587A Naofusu capsule for encephalopathy and preparation thereof
08/28/1996CN1129583A Ginseng and royal jelly chewing tablets and preparation thereof
08/28/1996CN1129582A Zhongfengkang instant powder for curing apoplexy
08/28/1996CN1129581A Formulation type of medicine for relieving inflammation and pain and preparation thereof
08/28/1996CN1129578A Formulation of Ganmaosuyusan for curing common cold
08/28/1996CN1129575A Red common stonecrop oral liquid and preparation thereof
08/28/1996CN1129573A Skin absorptive antiviral drug
08/28/1996CN1129572A Medicine for curing burn and scald
08/28/1996CN1129566A Inhalant for preventing and remitting acute attack of cardio-cerebral diseases and preparation thereof
08/28/1996CN1129561A Medicine liquid for tinea
08/27/1996US5550289 N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
08/27/1996US5550226 Stable free-flowing crystalline anticariogenic sweetner powder containing mixtures of panose and other oligosaccharides, for foods, beverages, chewing gums
08/27/1996US5550225 Reacting an acid in presence of a base with an alkyl chloroformate to form mixed anhydride, reacting formed anhydride with d-maltose in an organic solvent, evaporating solvent, performing liquid/liquid extraction
08/27/1996US5550178 Process for encapsulating biologics using crosslinkable biocompatible encapsulation system
08/27/1996US5550165 Containing 4-hydroxyphenylpyruvate dioxygenase inhibiting amount of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
08/27/1996US5550163 Method for reducing filtrate waste in a manufacturing process of a pharmaceutical product containing benzalkonium chloride
08/27/1996US5550050 Exposing cells enclosed in biocompatible capsules to restrictive environmental conditions which match those which will be encountered after implantation until desired responses are established
08/27/1996US5549917 Flash flow formed solloid delivery systems
08/27/1996US5549915 Magnetically responsive composition for carrying biologically active substances and methods of production
08/27/1996US5549913 Multilayer matrix systems for the controlled release of active principles
08/27/1996US5549912 Controlled release oxycodone compositions
08/27/1996US5549911 Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
08/27/1996US5549910 Preparation of liposome and lipid complex compositions
1 ... 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 ... 2991